Research progress on acupuncture treatment in central nervous system diseases based on NLRP3 inflammasome in animal models

Diseases of the central nervous system represent a growing challenge for modern medicine, affecting millions of people around the world and significantly compromising patients' quality of life. Among these conditions, stroke, Alzheimer's disease, vascular dementia, depression, and spinal cord injuries stand out, all characterized by complex mechanisms of neuroinflammation and cell death. Although conventional treatments have evolved, there is still an important gap in the management of these conditions, especially regarding the control of inflammation in the brain and spinal cord. It is in this context that acupuncture emerges as a promising therapeutic alternative, with growing evidence of its efficacy in the treatment of neurological disorders.

The study analyzed aimed to investigate how acupuncture influences the NLRP3 inflammasome, a protein complex crucial to the inflammatory response in the central nervous system, in the treatment of various neurological diseases. To this end, the researchers conducted a systematic review of the scientific literature, searching the main medical databases for articles relating acupuncture, the NLRP3 inflammasome, and central nervous system diseases. The methodology involved the search for animal studies that investigated the mechanisms by which different acupuncture modalities, including manual acupuncture and electroacupuncture, modulate NLRP3 inflammasome activation. The researchers also mapped the acupuncture points most frequently used in the treatment of these conditions, identifying specific locations such as Baihui, Zusanli, and other strategic points that demonstrated particular efficacy in the control of neuroinflammation.

The findings of the study revealed that acupuncture exerts its neuroprotective effects through multiple mechanisms related to the inhibition of the NLRP3 inflammasome. In animal models of vascular dementia, acupuncture demonstrated significant reduction of microglial activation, the brain immune cells responsible for the inflammatory response, while at the same time decreasing the production of harmful inflammatory substances. In Alzheimer's disease, the technique was shown to be capable of preserving cognitive function through the reduction of inflammatory protein expression and the protection of neurons against cell death. In cases of stroke, acupuncture facilitated neurological recovery by controlling the inflammatory cascade that develops after the initial brain tissue injury.

For depression, the treatment demonstrated antidepressant effects related to the modulation of the inflammatory response in the hippocampus, a brain region crucial for mood and memory. In spinal cord injuries, acupuncture promoted functional recovery through the reduction of local inflammation and protection of neurons against secondary damage.

The clinical implications of these findings are substantial for both patients and healthcare professionals. For patients, these findings suggest that acupuncture may offer a valuable additional therapeutic option, particularly important considering that many of these neurological conditions have limited treatment options in conventional medicine. The ability of acupuncture to modulate neuroinflammation through specific mechanisms provides a solid scientific basis for its clinical use, potentially resulting in better outcomes when integrated with standard medical care. For healthcare professionals, these results offer important insights into how to personalize acupuncture protocols, including the appropriate selection of specific points and electrical stimulation parameters.

The study also highlights the importance of considering acupuncture not just as a symptomatic therapy, but as an intervention that can influence the fundamental pathological processes underlying neurological diseases.

However, it is important to recognize the significant limitations of this work. First, all the studies analyzed were conducted on animal models, which means that we still need more research to confirm whether these same mechanisms occur in humans. In addition, there is considerable variability among the studies regarding the acupuncture protocols used, including different electrical stimulation frequencies, treatment duration, and point selection, making it difficult to establish standardized guidelines for clinical practice. The limited number of high-quality randomized controlled clinical trials also represents an important limitation in the clinical validation of these findings.

Despite these limitations, the research represents a significant advance in the understanding of the neurobiological mechanisms of acupuncture and establishes a solid basis for future clinical investigations that can translate these promising experimental results into tangible benefits for patients with central nervous system diseases.